
US initiative to reduce reliance on foreign drug manufacturing
The US Food and Drug Administration (FDA) has introduced FDA PreCheck, a new programme to facilitate the construction of manufacturing sites. More than half of pharmaceuticals distributed in the US are manufactured overseas and the US is reliant on overseas sources for active pharmaceutical ingredients (APIs). “Our gradual overreliance on… Read More















